PharmaCyte Biotech Dividends
| PMCB Stock | USD 0.78 0.04 5.41% |
At present, PharmaCyte Biotech's Dividend Yield is projected to increase slightly based on the last few years of reporting. The current year's Dividend Payout Ratio is expected to grow to 0.03, whereas Dividends Paid is forecasted to decline to about 1.2 M. PharmaCyte Biotech's past performance could be the main factor of why investors trade PharmaCyte Biotech stock today. Investors should clearly understand every aspect of the PharmaCyte Biotech dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest PharmaCyte Biotech's dividend schedule and payout information. PharmaCyte Biotech dividends can also provide a clue to the current valuation of PharmaCyte Biotech.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 1.3 M | 1.2 M | |
| Dividend Yield | 0.11 | 0.12 | |
| Dividend Payout Ratio | 0.03 | 0.03 | |
| Dividend Paid And Capex Coverage Ratio | (2.37) | (2.49) |
PharmaCyte | Build AI portfolio with PharmaCyte Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in PharmaCyte Biotech must own a stock before its ex-dividend date to receive its next dividend.
PharmaCyte Biotech Dividends Paid Over Time
Today, most investors in PharmaCyte Biotech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PharmaCyte Biotech's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PharmaCyte Biotech dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
PharmaCyte Biotech Historical Dividend Yield Growth
A solid dividend growth pattern of PharmaCyte Biotech could indicate future dividend growth is likely, which can signal long-term profitability for PharmaCyte Biotech. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is PharmaCyte Biotech dividend as a percentage of PharmaCyte Biotech stock price. PharmaCyte Biotech dividend yield is a measure of PharmaCyte Biotech stock productivity, which can be interpreted as interest rate earned on an PharmaCyte Biotech investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. Anticipated expansion of PharmaCyte directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PharmaCyte Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding PharmaCyte Biotech requires distinguishing between market price and book value, where the latter reflects PharmaCyte's accounting equity. The concept of intrinsic value - what PharmaCyte Biotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push PharmaCyte Biotech's price substantially above or below its fundamental value.
It's important to distinguish between PharmaCyte Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PharmaCyte Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PharmaCyte Biotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.